Gage R&R is all about the integrity of your measurement system and its ability to capture the true values of what you are ...

Your cup of coffee could be more beneficial for your body in the morning than later in the day. A US study found that a shot of morning coffee, rather than the all-day-anytime-cup pattern, was ...

Shares of GKOS were up almost 1% in after-hours trading on Jan. 14, following the positive study data readout. The company’s shares have gained 17.7% in the past six months against the industry ...

"Although we believe that further exploration along the 100km volcanogenic massive sulphide belt will extend the mine life of the Arctic Project beyond the 13 years established by the current Arctic ...

VANCOUVER, BC, Jan. 15, 2025 /CNW/ - Trilogy Metals Inc. (TSX: TMQ) (NYSE American: TMQ) ("Trilogy Metals" or the "Company") is pleased to announce the positive results of its Preliminary Economic ...

assumptions and discount rates being appropriately applied to the Bornite PEA and Arctic Feasibility Study, uncertainty as to whether there will ever be production at the Company's mineral exploration ...

Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.

(RTTNews) - Eterna Therapeutics, Inc. (ERNA) announced Tuesday positive results from a preclinical study on the company's lead cell therapy product, ERNA-101, which is designed to activate and ...

They found that 36% of the study participants were morning coffee drinkers, 16% drank their coffee throughout the day, and the rest (48%) didn't drink coffee at all. When they compared those who ...

today announced positive results from a preclinical study on the company’s lead cell therapy product, ERNA-101, which is designed to activate and regulate the immune system's response to ...

Positive data on presurgical response rates, previously shown to be indicative of overall survival, could enable us to apply for early approval,” stated CEL-SCI CEO, Geert Kersten. “This confirmatory ...